drugset / Trial / NCT03062618
A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
RandomizedCrossoverDouble-blindTreatment
Summary
This study consists of three parts: single oral dose escalation in healthy volunteers (Part A), and multiple oral dose escalations in healthy volunteers (Part B) and in participants with chronic plaque psoriasis (Part C)
Timeline
- Start
- 2017-02-20
- Primary completion
- 2018-02-08
- Completion
- 2018-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRCL-02 | Unknown | 4 mg | Oral |